The Microbiota–Gut–Brain Axis in Alzheimer’s Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions

Abstract

Objective The gut microbiome is a complex community of microorganisms that inhabit the gastrointestinal tract. The microbiota–gut–brain axis encompasses a bidirectional communication system that allows the gut to influence the brain via neural, endocrine, immune, and metabolic signaling. Differences in the gut microbiome have been associated with psychiatric and neurological disorders, including Alzheimer’s Disease (ad). Understanding these ad-associated alterations may offer novel insight into the pathology and treatment of ad. Method We conducted a narrative review of clinical studies investigating the gut microbiome in ad, organizing the results by phyla to understand the biological contributions of the gut microbial community to ad pathology and clinical features. We also reviewed randomized clinical trials of interventions targeting the microbiome to ameliorate ad symptoms and biomarkers. Results Alpha diversity is reduced in patients with ad. Within Firmicutes, taxa that produce beneficial metabolites are reduced in ad, including Clostridiaceae, Lachnospiraceae, Ruminococcus, and Eubacterium. Within Bacteroidetes, findings were mixed, with studies showing either reduced or increased abundance of Bacteroides in mild cognitive impairment or ad patients. Proteobacteria that produce toxins tend to be increased in ad patients, including Escherichia/Shigella. A Mediterranean-ketogenic dietary intervention significantly increased beneficial short-chain fatty acids and taxa that were inversely correlated with changes in ad pathological markers. Probiotic supplementation with Lactobacillus spp. and Bifidobacterium spp. improved cognitive function and reduced inflammatory and metabolic markers in patients with ad. Conclusions The gut microbiome may provide insight into ad pathology and be a novel target for intervention. Potential therapeutics include probiotics and dietary intervention.

The Role of Human Herpesvirus 6 Infection in Alzheimer’s Disease Pathogenicity—A Theoretical Mosaic

“…Finally, an intensely discussed hypothesis with a significant impact on many pathologies is the brain–gut microbiota axis. At present, there are only incipient human studies suggesting a weak association between specific types of gut bacteria (such as increased Proteobacteria or reduced Ruminococcus) and AD CSF markers [ 86 ]. Understanding the immunology and gut microbiota mechanisms that influence the brain’s normal function are mandatory for arriving at a conclusion.…”

The Microbiome–Gut–Brain Axis and Dementia: A Bibliometric Analysis

“…The brain–gut axis reflects bidirectional communication between central and enteric nervous systems [ 26 ]; as one of the main regulators of the brain–gut axis, the distribution of neuroactive compounds released by microbiota around the axis may lead to the changes of cognitive function that contribute to the development of dementia [ 29 ]. Specifically, dementia is hypothesized to arise when gut bacteria activate immune activation through a defective intestinal barrier and lead to systemic inflammation, that, in turn, disrupts the blood–brain barrier and promotes neuroinflammation, ultimately leading to nerve damage and degeneration [ 30 , 31 , 32 ]. Evidence based on a nationwide population-based cohort study supports this hypothesis, as irritable bowel syndrome patients are at higher risk of dementia compared to healthy controls [ 33 ].…”

Analysis of 16S rRNA gene sequence of nasopharyngeal exudate from healthy donors reveals changes in key microbial communities associated with aging

“…Among the remaining challenges in biomedical sciences, one of the most important is to fully understand how aging affects human biological processes, health, and wellness. In recent years, solid evidence has been found to support the idea that the microbial communities that inhabit the different anatomical areas of the human body could play a key role in these processes, and there has been much speculation about possible medical interventions [1][2][3][4][5][6] . Although most research has focused on the well-studied gut microbiome, there is growing evidence that variations in microbial communities in other sites of the body are also responsible for wide-ranging health effects [7][8][9][10][11] .…”